Genetic and metabolic factors are associated with increased hepatic iron stores in a selected population of p.Cys282Tyr heterozygotes

Blood Cells, Molecules, and Diseases

Volumn 44, Issue 3, 2010, Pages 159-163

  Mariani, R ^a   Pelucchi, S ^a   Arosio, C ^b   Coletti, S ^a   Pozzi, M ^a   Paolini, V ^a   Trombini, P ^c   Piperno, A ^a,b,c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Consortium for Human Molecular Genetics ^*  (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Hemochromatosis; Hepatic iron overload; HFE; Steatosis; Transferrin saturation

Indexed keywords

CYSTEINE; FERRITIN; FERROPORTIN; GLUTAMINE; HEMOJUVELIN; HEPCIDIN; HFE PROTEIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRANSFERRIN RECEPTOR 2; TYROSINE;

ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; GENETIC ANALYSIS; HEMOCHROMATOSIS; HEREDITY; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; LIVER BIOPSY; MALE; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHLEBOTOMY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; FERRITINS; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION;

EID: 76849110581     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2010.01.002     Document Type: Article

References (38)

1. Robson K.J., Merryweather-Clarke A.T., Cadet E., et al. Recent advances in understanding haemochromatosis: a transition state. J. Med. Genet. 41 (2004) 721-730
2. Pietrangelo A. Hereditary hemochromatosis. Biochim. Biophys. Acta 1763 (2006) 700-710
3. King C., and Barton D.E. Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosis. BMC Med. Genet. 7 (2006) 81
4. Piperno A., Arosio C., Fossati L., et al. Two novel nonsense mutations of HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology 119 (2000) 441-445
5. Beutler E., Griffin M.J., Gelbart T., and West C. A previously underscribed nonsense mutation of the HFE gene. Clin. Genet. 61 (2002) 40-42
6. Wallace D.F., Dooley J.S., and Walker A.P. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Gastroenterology 116 (1999) 1409-1412
7. Biasiotto G., Belloli S., Ruggeri G., et al. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Clin. Chem. 49 (2003) 1981-1988
8. Swinkels D.W., Venselaar H., Wiegerinck E.T., et al. A novel (Leu183Pro-)mutation in the HFE-gene co-inherited with the Cys282Tyr mutation in two unrelated Dutch hemochromatosis patients. Blood Cells Mol. Dis. 40 (2008) 334-338
9. Le Gac G., Dupradeau F.Y., Mura C., et al. Phenotypic expression of the C282Y/Q283P compound heterozygosity in HFE and molecular modeling of the Q283P mutation effect. Blood Cells Mol. Dis. 30 (2003) 231-237
10. Barton J.C., West C., Lee P.L., and Beutler E. A previously undescribed frameshift deletion mutation of HFE (c.del277; G93fs) associated with hemochromatosis and iron overload in a C282Y heterozygote. Clin. Genet. 66 (2004) 214-216
11. Mendes A.I., Ferro A., Martins R., et al. Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes. Ann. Hematol. 88 (2009) 229-234
12. Dupradeau F.Y., Pissard S., Coulhon M.P., et al. An unusual case of hemochromatosis due to a new compound heterozygosity in HFE (p.[Gly43Asp;His63Asp]+[Cys282Tyr]): structural implications with respect to binding with transferrin receptor 1. Hum. Mutat. 29 (2008) 206
13. Barton J.C., Sawada-Hirai R., Rothenberg B.E., and Acton R.T. Two novel missense mutations of the HFE gene (I105 T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol. Dis. 25 (1999) 147-155
14. Rosmorduc O., Poupon R., Nion I., et al. Differential HFE allele expression in hemochromatosis heterozygotes. Gastroenterology 119 (2000) 1075-1086
15. Biasiotto G., Roetto A., Daraio F., et al. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol. Dis. 33 (2004) 338-343
16. Merryweather-Clarke A.T., Cadet E., Bomford A., et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum. Mol. Genet. 12 (2003) 2241-2247
17. Pietrangelo A., Caleffi A., Henrion J., et al. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 128 (2005) 470-479
18. Barton J.C., Shih W.W., Sawada-Hirai R., et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol. Dis. 23 (1997) 135-145
19. Beutler E., Felitti V., Gelbart T., and Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann. Intern. Med. 133 (2000) 329-337
20. Bulaj Z.J., Griffen L.M., Jorde L.B., et al. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N. Engl. J. Med. 335 (1996) 1799-1805
21. Gandon Y., Olivié D., Guyader D., et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 363 (2004) 357-362
22. Deugnier Y.M., Loréal O., Turlin B., et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 102 (1992) 2050-2059
23. Deugnier Y.M., Turlin B., Powell L.W., et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology 17 (1993) 30-34
24. Mariani R., Pelucchi S., Perseghin P., et al. Erythrocytapheresis plus erythropoietin: an alternative therapy for selected patients with hemochromatosis and severe organ damage. Haematologica 90 (2005) 717-718
25. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
26. Riva A., Trombini P., Mariani R., et al. Revaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome. World J. Gastroenterol. 14 (2008) 4745-4752
27. Bennett M.J., Lebrón J.A., and Bjorkman P.J. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 403 (2000) 46-53
28. Schimanski L.M., Drakesmith H., Sweetland E., et al. In vitro binding of HFE to the cation-independent mannose-6 phosphate receptor. Blood Cells Mol. Dis. 43 (2009) 180-193
29. Fleming R.E., Holden C.C., Tomatsu S., et al. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2707-2711
30. Bensaid M., Fruchon S., Mazères C., et al. Multigenic control of hepatic iron loading in a murine model of hemochromatosis. Gastroenterology 126 (2004) 1400-1408
31. Milet J., Dehais V., Bourgain C., et al. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance. Am. J. Hum. Genet. 81 (2007) 799-807
32. Benyamin B., McRae A.F., Zhu G., et al. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am. J. Hum. Genet. 84 (2009) 60-65
33. Tanaka T., Roy C.N., Yao W., et al. A genome-wide association analysis of serum iron concentrations. Blood (2009 Oct 30) [Electronic publication ahead of print]
34. Zaahl M.G., Merryweather-Clarke A.T., Kotze M.J., et al. Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload. Hum. Genet. 115 (2004) 409-417
35. Mendler M.H., Turlin B., Moirand R., Jouanolle A.M., Sapey T., Guyader D., Le Gall J.Y., Brissot P., David V., and Deugnier Y. Insulin resistance-associated hepatic iron overload. Gastroenterology 117 (1999) 1155-1163
36. Fargion S., Mattioli M., Fracanzani A.L., et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am. J. Gastroenterol. 96 (2001) 2448:55
37. Barisani D., Pelucchi S., Mariani R., et al. Hepcidin and iron-related gene expression in subjects with dysmetabolic hepatic iron overload. J. Hepatol. 49 (2008) 123-133
38. Ruivard M., Lainé F., Ganz T., et al. Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. J. Hepatol. 50 (2009) 1219-1225